Fredun Pharmaceuticals informs about board meeting

19 Jun 2018 Evaluate

In compliance to Regulation 33 read with Regulation 30 along with Part A of Schedule 111 of SEBl Listing Regulations, 2015, Fredun Pharmaceuticals has informed that the Board of Directors of the Company, at its Meeting held on Monday, June 18, 2018, have considered and approved the Audited Financials for the year ended March 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

1650.85 31.15 (1.92%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×